Folate vs Folic Acid vs Methylfolate: What Differs
Key takeaways
- Folate is the umbrella term. Folic acid is the fully oxidized synthetic form used in fortification, and 5-MTHF is the reduced form that actually circulates in blood.
- Folic acid has to be reduced and then converted by the enzyme MTHFR. Methylfolate skips that step, which is the entire basis for the marketing claim.
- In a 12-week trial of 142 women, 1.13 mg of 5-MTHF raised red cell folate to 1,951 nmol/L against 1,498 nmol/L for 1 mg of folic acid, while homocysteine fell 15% and 17% with no difference between groups.
- MTHFR 677TT carriers, roughly 10% to 12% of many populations, start with lower folate and higher homocysteine, and they respond to ordinary folic acid at 400 µg a day.
- Mandatory fortification began in the US in 1998 at 140 µg per 100 g of enriched grain, and NTD prevalence fell about 35%, averting roughly 1,326 affected births a year. That evidence belongs to folic acid.
Three names, three different molecules
Folate is a family name, not a compound. It covers the naturally occurring vitamers in food, which arrive reduced and carrying a chain of several glutamate residues that has to be trimmed off before absorption. Folic acid is a single synthetic molecule, fully oxidized, with no glutamate tail, and it's the form in fortified flour and in most cheap supplements because it's stable and cheap. Methylfolate, or 5-MTHF, is the reduced, methylated form that dominates in plasma and in red cells. On a label it usually appears as a calcium or glucosamine salt, and the dose is expressed as the salt rather than as folic acid equivalents, which makes milligram comparisons between the two harder than the numbers suggest.
Different molecules, different stability, different prices.
What the body does with each one
Folic acid isn't bioactive. It has to be reduced twice by dihydrofolate reductase, an enzyme that runs slowly and variably in humans, and then methylated by MTHFR to become 5-MTHF, the form that circulates and donates methyl groups. That two-step conversion is where the "your body can't use folic acid" argument comes from. It's also why unmetabolized folic acid shows up in plasma when intake runs high, since the reductase step saturates. 5-MTHF arrives already reduced and already methylated, so it needs no MTHFR and no reductase. It is the substrate for methionine synthase, the B12-dependent reaction that turns homocysteine into methionine. Give either form and blood folate rises and homocysteine falls, because the body can convert folic acid into the same end product.
The pathway converges. Only the number of steps differs.
The MTHFR claim
The 677C>T variant substitutes valine for alanine and produces a less active enzyme, with the homozygous TT genotype found in roughly 10% to 12% of many populations. TT carriers do run higher homocysteine and lower folate when their intake is low, and that finding is solid. The claim built on top of it, that they can't convert folic acid and need methylfolate, doesn't follow. A randomised crossover in 126 adults, 42 of each genotype, gave 400 µg a day of folic acid for four months and raised plasma folate in every genotype. Supplementation lifted folate 79% and cut homocysteine 16% across the group, and the gap between TT and CC carriers narrowed rather than persisting. A separate controlled feeding study found that 400 µg a day brought TT carriers to normal blood folate and desirable homocysteine, concluding that the RDA was adequate for all three genotypes.
TT carriers need somewhat more folate. They don't need a different molecule.
What fortification did to neural tube defects
This is the part of the folate story with hard outcomes, and it belongs to folic acid. The MRC Vitamin Study randomised women who had already had an affected pregnancy to 4 mg of folic acid daily or placebo, starting before conception. Recurrence was 1.0% on folic acid against 3.5% without it, a relative risk of 0.29 (95% CI 0.12 to 0.71), which is a 71% reduction. The trial stopped early. Later, the US mandated fortification of enriched grain at 140 µg per 100 g from 1998, and surveillance across 19 programmes found NTD prevalence down about 35%, with roughly 1,326 affected births averted each year (95% CI 1,122 to 1,531). Prevalence has stayed flat since, and remains higher in Hispanic women, which is a coverage problem rather than a form problem.
There has never been a trial of methylfolate for NTD outcomes.
Does "active" mean better
For biomarkers, methylfolate has a modest edge on some measures and no edge on others. The Malaysian trial found red cell folate 30% higher with an equimolar dose at 12 weeks. A pharmacokinetic study in cardiac patients given a single 5 mg dose found 5-MTHF peaks roughly seven times higher than folic acid, regardless of genotype, though a single-dose peak is a poor proxy for steady-state status. Against that, homocysteine fell by the same amount in both arms of the Malaysian trial, and no trial has compared the forms on any clinical endpoint. Methylfolate costs more per milligram, and the biomarker differences are small enough that a general-population claim of superiority isn't established.
Better on a lab value. Unproven on anything a person would notice.
Frequently asked questions
Is methylfolate better than folic acid?
For raising blood folate, sometimes, by a modest margin. For lowering homocysteine, no difference has shown up. For preventing neural tube defects, there's no trial data at all, while folic acid has the trial that changed public health policy.
Do I need methylfolate if I have MTHFR variants?
Not on the evidence available. TT carriers respond to ordinary folic acid at 400 µg a day and reach normal folate status. They may need more folate than CC carriers, which is a dose question rather than a form question.
Is folic acid synthetic and therefore bad?
Synthetic isn't a safety category. Folic acid is the form with the outcome evidence, and unmetabolized folic acid in blood is a measurable phenomenon with theoretical concerns and no demonstrated harm at usual intakes.
How much folate do women need before pregnancy?
Public health guidance in the US is 400 µg of folic acid daily for anyone who could become pregnant, from fortified food, supplements or both. Women with a previously affected pregnancy are usually advised 4 mg under medical supervision.
Can I get enough from food alone?
It's hard to hit 400 µg from unfortified food, which is why fortification exists. Leafy greens, legumes and citrus carry folate, but the natural forms are less stable and less bioavailable than the synthetic one.
---
This article is for general information only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Talk with your health care provider before using folate supplements, especially if you take prescription medication.
Sources
- Henderson AM et al., l-5-Methyltetrahydrofolate increases blood folate more than folic acid in Malaysian women, J Nutr 2018
- Ashfield-Watt PA et al., MTHFR 677C-T genotype modulates homocysteine responses to folate, Am J Clin Nutr 2002
- Pullin CH et al., Dietary folate or low-dose folic acid lower homocysteine but do not enhance endothelial function, irrespective of MTHFR genotype, J Am Coll Cardiol 2001
- Pharmacokinetics of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease, Br J Pharmacol 2004
- Williams J et al., Updated estimates of neural tube defects prevented by mandatory folic acid fortification, MMWR 2015
- CDC, Use of folic acid for prevention of spina bifida and other neural tube defects: MRC Vitamin Study results, MMWR